Papers by The 25% M.E Group, with the aid of Dr Vance Spence and MERUK,
Charity No 1080201
Telephone and Fax: 01738 451234
meruk@pkavs.org.uk
Purpose: This report, created by MERGE (now ME Research UK) and The 25% ME Group, shines a spotlight on the lack of scientific research focused on the most severely ill Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients. It explores existing gaps, shares current findings, and calls for urgent attention to this often invisible population. Key Points:…
Purpose: This report by ME Research UK highlights findings from one of the first biomedical research projects investigating the quality of life of children with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Conducted by Dr. Gwen Kennedy’s team at the University of Dundee, the study aimed to objectively compare the health and social outcomes of children with…
Purpose: This document, published in the 25% ME Group Newsletter (Winter 2000), provides a comprehensive overview of current biomedical research and challenges associated with ME/CFS. It aims to bridge the divide between biological and psychological schools of thought, advocating for greater clarity in diagnostic criteria and treatment approaches. Key Points: Issues with Terminology and Definition…
Purpose: This report from ME Research UK summarizes findings by Dr. Faisel Khan and his team at the Vascular Diseases Research Unit, University of Dundee. The study investigates arterial stiffness and its potential relationship to inflammation in Myalgic Encephalomyelitis (ME) patients, shedding light on biological abnormalities associated with the condition. Key Points: Overview of Recent…
Purpose: This document highlights recent research led by Dr. Gwen Kennedy and Dr. Faisel Khan at the University of Dundee, investigating the biochemical and vascular abnormalities in children with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Funded by ME Research UK, The Young ME Sufferers (Tymes) Trust, and Search ME, the study explores the long-term health implications…
Author: Dr. Neil Abbot, MERGE Purpose: This document explores the neurological aspects of Myalgic Encephalomyelitis (ME), focusing on recent findings of reduced brain gray matter volume in ME patients. It highlights the implications of these findings for understanding the disease’s pathophysiology and its impact on patients. Key Points: Neurological Symptoms in ME Central nervous system…
Purpose: This document, summarized by Dr. Neil Abbot from Dr. J. Gordon Parish’s detailed review, explores the clinical and historical understanding of Myalgic Encephalomyelitis (ME). It examines the disease’s origins, notable outbreaks, and its impact on muscles and the brain. Key Points: Historical Outbreaks of ME From 1934 to 1959, at least 23 documented epidemics…
Purpose: Prepared by ME Research Group for Education and Support (MERGE) in April 2002, this document evaluates the January 2002 report produced by the Chief Medical Officer’s (CMO) Working Group on Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME). MERGE highlights both the report’s positive strides and its shortcomings in addressing ME/CFS’s complex challenges, aiming to advocate…
Purpose: ME Research UK (formerly MERGE) announces funding for a longitudinal cohort study led by Dr. Julia Newton at the University of Newcastle. This study investigates autonomic dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and explores its implications for patient outcomes and mortality risk. Key Points: Research Objectives: The study aims to determine the prevalence…